POTENTIATING LONG-LIVED ANTITUMOR EFFECTOR CD8+ T CELLS FOR TNBC THERAPY

$1,600,000FY2025Defense Health AgencyDOD

Northwestern University, Evanston IL

Investigators

View source on USAspending →